Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB) EBITDA Margin (2024 - 2025)

Historic EBITDA Margin for Nuvation Bio (NUVB) over the last 2 years, with Q3 2025 value amounting to 423.81%.

  • Nuvation Bio's EBITDA Margin rose 48805900.0% to 423.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 818.75%, marking a year-over-year increase of 235846700.0%. This contributed to the annual value of 7208.78% for FY2024, which is N/A changed from last year.
  • Per Nuvation Bio's latest filing, its EBITDA Margin stood at 423.81% for Q3 2025, which was up 48805900.0% from 1238.94% recorded in Q2 2025.
  • Nuvation Bio's EBITDA Margin's 5-year high stood at 423.81% during Q3 2025, with a 5-year trough of 32236.17% in Q2 2024.